Dr. Connie Vance is a pharmacologist with expertise in biochemistry, medicinal chemistry, and neuroscience. Her graduate work focused on neuromodulation of the dopaminergic system in the CNS. Her dissertation centered around the structure-activity relationships of ligands for a novel sigma-like receptor that modulated striatal dopaminergic activity as a potential Parkinson’s disease treatment. As a postdoctoral research fellow at the Mental Health Research Institute at the University of Michigan, Dr. Vance explored the molecular determinants of opioid receptor binding and activation. She subsequently worked at two start-up biotechnology companies where she gained extensive experience in both drug and diagnostic development, successfully established external collaborations, and was instrumental in securing grant funding. Dr. Vance is the co-author of “Adenosine Receptors and Inflammation in Adenosine Receptors in Health and Disease” in the Handbook of Experimental Pharmacology. Dr. Vance is also an experienced educator serving as course coordinator and lecturer in medicinal chemistry at the UNC School of Pharmacy. She taught fundamental courses in the medicinal chemistry and pharmacology of drugs used to treat cardiovascular and CNS disorders and drugs that affect the adrenergic system. In her free time, Dr. Vance coaches a middle school Science Olympiad team. She also trains in To-Shin Do ninjitsu and teaches women’s self-defense classes.
Education: B.S. in Biology from King College; Ph.D. in Medicinal Chemistry and Natural Products from the School of Pharmacy at the University of North Carolina at Chapel Hill.